ATE126702T1 - Verfahren zur herstellung von impfstoffen gegen rna-virus. - Google Patents

Verfahren zur herstellung von impfstoffen gegen rna-virus.

Info

Publication number
ATE126702T1
ATE126702T1 AT90909343T AT90909343T ATE126702T1 AT E126702 T1 ATE126702 T1 AT E126702T1 AT 90909343 T AT90909343 T AT 90909343T AT 90909343 T AT90909343 T AT 90909343T AT E126702 T1 ATE126702 T1 AT E126702T1
Authority
AT
Austria
Prior art keywords
cells
rna virus
virus
vaccines against
against rna
Prior art date
Application number
AT90909343T
Other languages
English (en)
Inventor
Gordon Robert Bruce Ha Skinner
Alexander Buchan
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Birmingham filed Critical Univ Birmingham
Application granted granted Critical
Publication of ATE126702T1 publication Critical patent/ATE126702T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
AT90909343T 1989-06-14 1990-06-12 Verfahren zur herstellung von impfstoffen gegen rna-virus. ATE126702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913665A GB8913665D0 (en) 1989-06-14 1989-06-14 Method of preparing vaccines against rna viruses

Publications (1)

Publication Number Publication Date
ATE126702T1 true ATE126702T1 (de) 1995-09-15

Family

ID=10658419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909343T ATE126702T1 (de) 1989-06-14 1990-06-12 Verfahren zur herstellung von impfstoffen gegen rna-virus.

Country Status (8)

Country Link
EP (1) EP0477240B1 (de)
JP (1) JP2973372B2 (de)
AT (1) ATE126702T1 (de)
AU (1) AU637114B2 (de)
CA (1) CA2060198C (de)
DE (1) DE69021879T2 (de)
GB (1) GB8913665D0 (de)
WO (1) WO1990015622A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1267591A (en) * 1969-02-26 1972-03-22 Nat Res Dev Antigenic materials
IL68219A0 (en) * 1982-03-24 1983-06-15 Univ Birmingham Vaccine against dna viruses
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)

Also Published As

Publication number Publication date
AU637114B2 (en) 1993-05-20
JPH04506209A (ja) 1992-10-29
DE69021879D1 (de) 1995-09-28
EP0477240B1 (de) 1995-08-23
JP2973372B2 (ja) 1999-11-08
AU5832690A (en) 1991-01-08
GB8913665D0 (en) 1989-08-02
WO1990015622A1 (en) 1990-12-27
CA2060198C (en) 2000-05-02
DE69021879T2 (de) 1996-04-04
EP0477240A1 (de) 1992-04-01
CA2060198A1 (en) 1990-12-15

Similar Documents

Publication Publication Date Title
SE9003978D0 (sv) Dna expressionssystem baserade paa ett virus replikon
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
DE69333814D1 (de) Genetischer impfstoff gegen den immunschwäche virus
ATE140031T1 (de) Rekombinante poxvirusinnenkerne
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
EE200300331A (et) Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin
BR9814204A (pt) "obtenção de vacinas destinadas a prevenir os efeitos patogênicos associados a uma infecção retroviral"
DE3768833D1 (de) Verfahren zur herstellung von hcmv-glykoproteinen, antikoerper dagegen und hcmv-vakzine und dazu zu verwendende rekombinante vektoren.
ATA29997A (de) Verfahren zur inaktivierung von lipidumhüllten viren
BR0016145A (pt) Clones infecciosos
DE68915165T2 (de) Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
ATE365206T1 (de) Verfahren zur entwicklung von einem hiv impfstoff
ES553757A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ATE36956T1 (de) Verfahren zu herstellung von lebenden, adjuvierten impfstoffen und so erhaltende lebende, adjuvierte impfstoffe.
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
EP0967223A3 (de) Hepatitis C Virus Peptidantigene und Verfahren zur Bestimung von Hepatitis C Virus (HCV)
ATE126702T1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
DK8789A (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
BRPI0209416A8 (pt) novos vetores de expressão e uso dos mesmos
PT91316A (pt) Processo para a preparacao de vectores recombinantes e de particulas hbsag recombinantes hibridas tendo as caracteristicas morfologicas do antigenio hbsag contendo uma sequencia imunogenica que induz anticorpos neutralizantes dirigidos contra hiv ou susceptivel de ser reconhecida por tais anticorpos
FI95871B (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties